Format

Send to

Choose Destination
Kidney Int. 2019 Jun;95(6):1280-1283. doi: 10.1016/j.kint.2019.01.047.

Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD): establishing a core outcome set for trials in patients with glomerular disease.

Author information

1
Sydney School of Public Health, The University of Sydney, Sydney, Australia; Centre for Kidney Research, The Children's Hospital at Westmead, Sydney, Australia. Electronic address: simon.carter@health.nsw.gov.au.
2
Faculty of Medicine, Centre for Inflammatory Disease, Imperial College London, London, UK.
3
Faculty of Medicine, University of Toronto, Toronto, Canada; Toronto General Research Institute, Toronto, Canada.
4
Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.
5
Department of Medicine, Division of Nephrology, University of British Columbia, Vancouver, Canada.
6
Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, UK; John Walls Renal Unit, Leicester General Hospital, Leicester, UK.
7
Nephrology Department and Renal Transplantation Unit, Laiko Hospital, Athens, Greece.
8
Division of Nephrology, University of Louisville, Louisville, Kentucky, USA.
9
Fondazione Ricerca Molinette, Regina Margherita Hospital, Turin, Italy.
10
Department of Internal Medicine, Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.
11
Department of Nephrology and Clinical Immunology, RWTH University Hospital, Aachen, Germany.
12
Faculty of Medicine, University of Toronto, Toronto, Canada; Sunnybrook Health Sciences Centre, Toronto, Canada.
13
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
14
Department of Nephrology, Monash Health, Victoria, Australia; Centre for Inflammatory Diseases, Monash University Department of Medicine, Victoria, Australia.
15
Stanford University Medical Center, Stanford, California, USA; Department of Medicine, Division of Nephrology, Stanford University, Stanford, California, USA.
16
Nephrology Department, Hospital Fernández, Buenos Aires, Argentina.
17
Columbia University Medical Center, New York, New York, USA; Division of Nephrology, New York Presbyterian Hospital, New York, New York, USA.
18
Department of Internal Medicine, Division of Nephrology, Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
19
Renal Division of Peking University First Hospital, Beijing, China.
20
Sydney School of Public Health, The University of Sydney, Sydney, Australia; Centre for Kidney Research, The Children's Hospital at Westmead, Sydney, Australia.
21
Centre for Kidney Research, The Children's Hospital at Westmead, Sydney, Australia.
22
Division of Nephrology and Hypertension, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, USA.
23
Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia; Australasian Kidney Trials Network, University of Queensland, Brisbane, Australia; Translational Research Institute, Brisbane, Australia.
24
College of Medicine and Public Health, Flinders University, Adelaide, Australia.
25
Westmead Institute for Medical Research, The University of Sydney, Sydney, Australia; Sydney Medical School, The University of Sydney, Sydney, Australia.
26
Department of Nephrology, Monash Health, Victoria, Australia; Department of Medicine, Monash University, Victoria, Australia.
27
Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia; Australasian Kidney Trials Network, University of Queensland, Brisbane, Australia.
28
Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, China.
29
Department of Nephrology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.

KEYWORDS:

chronic kidney disease; clinical trials; core outcome set; glomerulonephritis; outcomes research; patient-centered outcomes

PMID:
31122702
DOI:
10.1016/j.kint.2019.01.047

Supplemental Content

Loading ...
Support Center